GBS ORANGE BROTH is used for the rapid identification of β-hemolytic Streptococcus Group B (GBS). Orange-staining β-hemolytic GBS occurs in 95.3 to 99.5% of all GBS strains isolated from clinical specimens.
Testing and diagnosis of Streptococcus agalactiae (Group B Streptococcus – GBS) during pregnancy are important for prevention of serious complications in the newbornEarly diagnosis and preventive antibiotic treatment significantly reduce the risk to the baby, essentially contributing to protecting the health of both the baby and the mother.
In the context of prenatal care, testing for the presence of GBS is usually performed between the 35th and 37th week of pregnancy, ensuring the timely adoption of the necessary preventive measures.
